Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)
CNY 6.29
(1.78%)
CNY 6.29
(1.78%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 491.63 Million CNY | -30.87% |
| 2022 | 711.19 Million CNY | -8.36% |
| 2021 | 776.09 Million CNY | -0.49% |
| 2020 | 779.9 Million CNY | -29.65% |
| 2019 | 1.1 Billion CNY | 5.56% |
| 2018 | 1.05 Billion CNY | 113.94% |
| 2017 | 490.85 Million CNY | 150.21% |
| 2016 | 196.17 Million CNY | 5.38% |
| 2015 | 186.16 Million CNY | 26.54% |
| 2014 | 147.11 Million CNY | -16.1% |
| 2013 | 175.35 Million CNY | 10.41% |
| 2012 | 158.82 Million CNY | 53.21% |
| 2011 | 103.66 Million CNY | 11.0% |
| 2010 | 93.38 Million CNY | 12.51% |
| 2009 | 83 Million CNY | 9.7% |
| 2008 | 75.67 Million CNY | 22.01% |
| 2007 | 62.01 Million CNY | 47.89% |
| 2006 | 41.93 Million CNY | 4.54% |
| 2005 | 40.11 Million CNY | 46.33% |
| 2004 | 27.41 Million CNY | 49.86% |
| 2003 | 18.29 Million CNY | 10.3% |
| 2002 | 16.58 Million CNY | 146.59% |
| 2001 | 6.72 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 83.93 Million CNY | -41.65% |
| 2024 Q3 | 120.58 Million CNY | 67.13% |
| 2024 Q2 | 70.83 Million CNY | -15.6% |
| 2023 Q1 | 134.42 Million CNY | -34.09% |
| 2023 Q2 | 127.51 Million CNY | -5.14% |
| 2023 Q3 | 143.56 Million CNY | 12.59% |
| 2023 Q4 | 143.85 Million CNY | 0.2% |
| 2023 FY | 491.63 Million CNY | -30.87% |
| 2022 Q2 | 168.64 Million CNY | 17.17% |
| 2022 Q3 | 194.63 Million CNY | 15.41% |
| 2022 Q4 | 203.96 Million CNY | 4.79% |
| 2022 FY | 711.19 Million CNY | -8.36% |
| 2022 Q1 | 143.93 Million CNY | -39.41% |
| 2021 Q3 | 172.91 Million CNY | -21.26% |
| 2021 Q4 | 237.56 Million CNY | 37.39% |
| 2021 FY | 776.09 Million CNY | -0.49% |
| 2021 Q2 | 219.59 Million CNY | 50.39% |
| 2021 Q1 | 146.01 Million CNY | -36.12% |
| 2020 Q3 | 194.59 Million CNY | -21.33% |
| 2020 Q1 | 109.38 Million CNY | -69.53% |
| 2020 Q2 | 247.36 Million CNY | 126.15% |
| 2020 Q4 | 228.56 Million CNY | 17.46% |
| 2020 FY | 779.9 Million CNY | -29.65% |
| 2019 FY | 1.1 Billion CNY | 5.56% |
| 2019 Q2 | 281.01 Million CNY | 45.8% |
| 2019 Q1 | 192.73 Million CNY | -41.59% |
| 2019 Q3 | 275.86 Million CNY | -1.83% |
| 2019 Q4 | 358.91 Million CNY | 30.1% |
| 2018 Q2 | 268.49 Million CNY | 53.95% |
| 2018 Q4 | 329.97 Million CNY | 19.02% |
| 2018 FY | 1.05 Billion CNY | 113.94% |
| 2018 Q1 | 174.4 Million CNY | -24.7% |
| 2018 Q3 | 277.25 Million CNY | 3.26% |
| 2017 Q3 | 133 Million CNY | 78.56% |
| 2017 Q2 | 74.48 Million CNY | 43.92% |
| 2017 Q1 | 51.75 Million CNY | -28.77% |
| 2017 FY | 490.85 Million CNY | 150.21% |
| 2017 Q4 | 231.6 Million CNY | 74.14% |
| 2016 Q1 | 33.78 Million CNY | -59.04% |
| 2016 FY | 196.17 Million CNY | 5.38% |
| 2016 Q4 | 72.65 Million CNY | 44.41% |
| 2016 Q3 | 50.31 Million CNY | 27.61% |
| 2016 Q2 | 39.42 Million CNY | 16.72% |
| 2015 Q4 | 82.46 Million CNY | 145.98% |
| 2015 Q2 | 35.5 Million CNY | 2.43% |
| 2015 FY | 186.16 Million CNY | 26.54% |
| 2015 Q1 | 34.66 Million CNY | -25.47% |
| 2015 Q3 | 33.52 Million CNY | -5.59% |
| 2014 Q3 | 41.77 Million CNY | 47.16% |
| 2014 Q4 | 46.51 Million CNY | 11.35% |
| 2014 FY | 147.11 Million CNY | -16.1% |
| 2014 Q1 | 30.44 Million CNY | -58.69% |
| 2014 Q2 | 28.38 Million CNY | -6.77% |
| 2013 Q1 | 23.78 Million CNY | -74.15% |
| 2013 Q3 | 31.86 Million CNY | -30.73% |
| 2013 Q4 | 73.7 Million CNY | 131.31% |
| 2013 FY | 175.35 Million CNY | 10.41% |
| 2013 Q2 | 45.99 Million CNY | 93.39% |
| 2012 Q2 | 23.66 Million CNY | -4.07% |
| 2012 Q1 | 24.66 Million CNY | -38.75% |
| 2012 Q4 | 92.01 Million CNY | 397.83% |
| 2012 FY | 158.82 Million CNY | 53.21% |
| 2012 Q3 | 18.48 Million CNY | -21.88% |
| 2011 FY | 103.66 Million CNY | 11.0% |
| 2011 Q4 | 40.27 Million CNY | 104.25% |
| 2011 Q3 | 19.71 Million CNY | -25.14% |
| 2011 Q1 | 17.33 Million CNY | -60.06% |
| 2011 Q2 | 26.33 Million CNY | 51.89% |
| 2010 Q1 | 14.89 Million CNY | -60.59% |
| 2010 FY | 93.38 Million CNY | 12.51% |
| 2010 Q2 | 17.02 Million CNY | 14.29% |
| 2010 Q3 | 18.05 Million CNY | 6.01% |
| 2010 Q4 | 43.41 Million CNY | 140.49% |
| 2009 FY | 83 Million CNY | 9.7% |
| 2009 Q4 | 37.8 Million CNY | 133.36% |
| 2009 Q3 | 16.2 Million CNY | 6.22% |
| 2009 Q2 | 15.25 Million CNY | 10.91% |
| 2009 Q1 | 13.75 Million CNY | -53.61% |
| 2008 Q4 | 29.64 Million CNY | 62.43% |
| 2008 Q3 | 18.24 Million CNY | 1.43% |
| 2008 Q2 | 17.99 Million CNY | 83.78% |
| 2008 Q1 | 9.78 Million CNY | -60.43% |
| 2008 FY | 75.67 Million CNY | 22.01% |
| 2007 Q1 | 4.29 Million CNY | -70.41% |
| 2007 FY | 62.01 Million CNY | 47.89% |
| 2007 Q4 | 24.73 Million CNY | 46.88% |
| 2007 Q3 | 16.84 Million CNY | 4.35% |
| 2007 Q2 | 16.14 Million CNY | 275.59% |
| 2006 Q1 | 8.94 Million CNY | -49.07% |
| 2006 Q2 | 10.37 Million CNY | 15.94% |
| 2006 FY | 41.93 Million CNY | 4.54% |
| 2006 Q3 | 8.09 Million CNY | -21.92% |
| 2006 Q4 | 14.52 Million CNY | 79.38% |
| 2005 Q1 | 5.8 Million CNY | -31.56% |
| 2005 Q2 | 9.36 Million CNY | 61.35% |
| 2005 FY | 40.11 Million CNY | 46.33% |
| 2005 Q3 | 7.39 Million CNY | -21.02% |
| 2005 Q4 | 17.56 Million CNY | 137.55% |
| 2004 Q3 | 6.31 Million CNY | -8.71% |
| 2004 Q2 | 6.91 Million CNY | 21.18% |
| 2004 Q4 | 8.47 Million CNY | 34.26% |
| 2004 FY | 27.41 Million CNY | 49.86% |
| 2004 Q1 | 5.7 Million CNY | -4.58% |
| 2003 Q4 | 5.98 Million CNY | 28.68% |
| 2003 FY | 18.29 Million CNY | 10.3% |
| 2003 Q3 | 4.64 Million CNY | 0.0% |
| 2002 FY | 16.58 Million CNY | 146.59% |
| 2001 FY | 6.72 Million CNY | 0.0% |